n-methyl-3,4-methylenedioxyamphetamine has been researched along with arginine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cadet, JL; Cerruti, C; Epstein, CJ; Ladenheim, B; Sheng, P | 1 |
Commandeur, JN; Damsten, MC; Maasdijk, DM; van Vugt-Lussenburg, BM; Vermeulen, NP | 1 |
Atila, C; Christ-Crain, M; Eckert, A; Heinrichs, M; Holze, F; Hutter, N; Liechti, ME; Murugesu, R; Rommers, N; Sailer, CO; Varghese, N | 1 |
1 trial(s) available for n-methyl-3,4-methylenedioxyamphetamine and arginine
Article | Year |
---|---|
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Topics: Arginine; Case-Control Studies; Cross-Over Studies; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Double-Blind Method; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin | 2023 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and arginine
Article | Year |
---|---|
Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro.
Topics: Adenosine Diphosphate Ribose; Animals; Arginine; Brain; Cell Death; Cells, Cultured; Dopamine; Dopamine Agents; Female; Free Radicals; Gene Expression Regulation; Gliosis; Illicit Drugs; Methamphetamine; Mice; Mice, Transgenic; N-Methyl-3,4-methylenedioxyamphetamine; Nitric Oxide; Oxidative Stress; Pregnancy; Serotonin; Serotonin Agents; Superoxide Dismutase | 1995 |
Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3.
Topics: Acetaminophen; Amodiaquine; Arginine; Benzoflavones; Caffeine; Cytochrome P-450 Enzyme System; Dextromethorphan; Enzyme Activation; Humans; Kinetics; Leucine; Molecular Structure; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Phenylalanine; Substrate Specificity | 2006 |